Medicaments for the treatment of toxoplasmosis

Details Medicaments for the treatment of toxoplasmosis Medicaments for the treatment of toxoplasmosis

1995-06-06

1999-01-05

Stockton, Laura L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ketone doai

568328, A61K 3112

Patent

active

058563628

ABSTRACT:
The present invention relates to the use of physiologically acceptable salt or other physiologically funtional derivative thereof for the manufacture of a medicament for the treatment and/or prophylaxis of toxoplasmosis in animals, to pharmaceutical compositions for the treatment and/or prophylaxis of toxoplasmosis, comprising said compound as active ingredient and to a method of treating or preventing toxoplasmosis in an animal which comprises administering to said animal an effective amount of said compound.

REFERENCES:
patent: 4981874 (1991-01-01), Latter et al.
patent: 5310762 (1994-05-01), Latter et al.
Hudson et al., Parasitology (1985) vol. 90, pp. 45-55.

Affiliated with

Also associated with

Rating

Medicaments for the treatment of toxoplasmosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments for the treatment of toxoplasmosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the treatment of toxoplasmosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-862766